Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $97,724 | 35 | 76.0% |
| Travel and Lodging | $21,614 | 45 | 16.8% |
| Food and Beverage | $4,072 | 62 | 3.2% |
| Consulting Fee | $2,800 | 1 | 2.2% |
| Honoraria | $2,250 | 1 | 1.7% |
| Education | $124.27 | 30 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $121,422 | 120 | $0 (2024) |
| Amgen Inc. | $3,073 | 4 | $0 (2024) |
| Horizon Therapeutics plc | $2,361 | 5 | $0 (2023) |
| Horizon Pharma plc | $1,109 | 8 | $0 (2018) |
| BioMarin Pharmaceutical Inc. | $317.70 | 4 | $0 (2019) |
| Shire North American Group Inc | $175.47 | 3 | $0 (2019) |
| Travere Therapeutics, Inc. | $68.91 | 22 | $0 (2023) |
| Ultragenyx Pharmaceutical Inc. | $30.00 | 1 | $0 (2021) |
| Retrophin, Inc. | $25.36 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $67,044 | 47 | GENZYME CORPORATION ($63,971) |
| 2023 | $32,897 | 39 | GENZYME CORPORATION ($32,841) |
| 2022 | $5,276 | 16 | GENZYME CORPORATION ($5,237) |
| 2021 | $9,265 | 11 | GENZYME CORPORATION ($6,967) |
| 2020 | $3,187 | 13 | GENZYME CORPORATION ($3,150) |
| 2019 | $7,948 | 25 | GENZYME CORPORATION ($7,808) |
| 2018 | $1,340 | 12 | Horizon Pharma plc ($1,109) |
| 2017 | $1,625 | 11 | GENZYME CORPORATION ($1,378) |
All Payment Transactions
174 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/23/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,400.00 | General |
| Category: Genetic Disease | ||||||
| 11/23/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $1,129.66 | General |
| Category: Genetic Disease | ||||||
| 11/23/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $923.96 | General |
| Category: Genetic Disease | ||||||
| 11/23/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $130.19 | General |
| Category: Genetic Disease | ||||||
| 11/23/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $126.03 | General |
| Category: Genetic Disease | ||||||
| 11/09/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,072.00 | General |
| Category: Genetic Disease | ||||||
| 11/09/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $74.52 | General |
| Category: Genetic Disease | ||||||
| 11/09/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $24.82 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $44.37 | General |
| 08/21/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $38.66 | General |
| 07/10/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,560.00 | General |
| Category: Genetic Disease | ||||||
| 07/06/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,608.00 | General |
| Category: Genetic Disease | ||||||
| 07/06/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $1,094.11 | General |
| Category: Genetic Disease | ||||||
| 07/06/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $118.26 | General |
| Category: Genetic Disease | ||||||
| 06/01/2024 | GENZYME CORPORATION | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,120.00 | General |
| 05/09/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,656.00 | General |
| Category: Genetic Disease | ||||||
| 05/09/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $870.21 | General |
| Category: Genetic Disease | ||||||
| 05/09/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | Cash or cash equivalent | $179.19 | General |
| Category: Genetic Disease | ||||||
| 05/09/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $141.95 | General |
| Category: Genetic Disease | ||||||
| 05/09/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $98.55 | General |
| Category: Genetic Disease | ||||||
| 05/08/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,280.00 | General |
| Category: Genetic Disease | ||||||
| 05/08/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $917.20 | General |
| Category: Genetic Disease | ||||||
| 05/08/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $413.10 | General |
| Category: Genetic Disease | ||||||
| 04/28/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,792.00 | General |
| Category: Genetic Disease | ||||||
| 04/20/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological), LUMIZYME | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,792.00 | General |
| Category: Genetic Disease | ||||||
About Dr. Jose Camacho, MD
Dr. Jose Camacho, MD is a Pediatrics healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1255548327.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jose Camacho, MD has received a total of $128,583 in payments from pharmaceutical and medical device companies, with $67,044 received in 2024. These payments were reported across 174 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($97,724).
Practice Information
- Specialty Pediatrics
- Other Specialties Clinical Genetics (M.D.)
- Location San Francisco, CA
- Active Since 05/17/2007
- Last Updated 05/13/2025
- Taxonomy Code 208000000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255548327
Products in Payments
- FABRAZYME (Biological) $57,493
- XENPOZYME (Biological) $43,937
- FABRAZYME (Drug) $6,620
- RAVICTI (Biological) $3,073
- NO PRODUCT DISCUSSED (Drug) $2,566
- PROCYSBI (Drug) $2,250
- NEXVIAZYME (Biological) $1,792
- RAVICTI (Drug) $1,147
- LUMIZYME (Biological) $706.50
- Vimizim (Biological) $197.74
- VPRIV (Biological) $162.15
- Naglazyme (Biological) $119.96
- NO_PRODUCT (Drug) $72.99
- DISEASE STATE (Drug) $70.00
- (820) Cholbam (Drug) $61.90
- Cholbam (Drug) $32.37
- Dojolvi (Drug) $30.00
- ELAPRASE (Biological) $13.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in San Francisco
Dr. David Kessler, M.d, M.D
Pediatrics — Payments: $424,231
Dr. Tonya Chaffee, Md, MD
Pediatrics — Payments: $400,708
Dr. Jonathan Strober, M.d, M.D
Pediatrics — Payments: $236,818
Saleh Adi, M.d, M.D
Pediatrics — Payments: $103,628
Dr. Stephen Gitelman, M.d, M.D
Pediatrics — Payments: $94,979
Dr. William Soulsby, Md, MD
Pediatrics — Payments: $80,000